In vitro inhibition of proliferation of HL-60 cells by tetrandrine and Coriolus versicolor peptide derived from Chinese medicinal herbs

Life Sciences

Volumn 60, Issue 8, 1997, Pages PL135-PL140

  Dong, Ying ^a   Yang, Mabel Mei Po ^a   Kwan, Chiu Yin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

apoptosis; berbamine; cancer; Coriolus versicolor; HL 60 cells; tetrandrine

Indexed keywords

BERBAMINE; BISBENZYLISOQUINOLINE ALKALOID; CORIOLUS VERSICOLOR EXTRACT; DNA; DNA FRAGMENT; PEPTIDE; PLANT EXTRACT; TETRANDRINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRUCTURE; CHINESE HERB; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEDICINAL PLANT; PERIPHERAL LYMPHOCYTE;

CORIOLUS VERSICOLOR; ZIZIPHUS MAURITIANA;

EID: 0031575410     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(96)00695-9     Document Type: Article

References (20)

1. 1. M. NIIMOTO, T. HATTORI, R. TAMADA, T. SUGIMACHI, K. INOBUCHI and N. C. OGAWA, Jpn. J. Surg. 18 681-686 (1988).
2. 2. T.F. LIU, Recent Advance in Cancer, 63-66, Chinese University Press, Hong Kong (1989).
3. 3. Y. KIKUCHI, I.. KIZZAWA, K. OOMORI, Y. KITA and K. KATO, Jpn. J. Cancer Res. 79 125-130 (1988).
4. 4. Y. DONG, C.Y. KWAN, Z.N. CHEN and M. YANG, Res. Commun. Mol, Pathol. Pharmacol. 92 140-148 (1996).
5. 5. M.M.P. YANG, Z.N. CHEN and J.S.L. KWOK, Amer. J. Chin. Med. 20 221-232 (1992).
6. 6. T. FUJII, T. KANO, K. SAITO, Y. KOBAYASHI, H. IIJIMA, T. MATSUMOTO, C. YOSHIKUMI and T. TAGUCHI, Anticancer Res. 7 845-848 (1987).
7. 7. X.Y., LI, J.F., WANG, P.P. ZHU, S.X. YANG, L. LIU and J.B. GE, Eur. J. Pharmacol. 183 904-905 (1990).
8. 8. H. KURODA, S. NAKAZAWA, K. KATAGIRI, O. SHIRATORI, M. KOZUKA, K. FUJITANI and M. TOMITA, Chem. Pharm. Bull. 24 2413-2420 (1976).
9. 9. Y. KONDO, Y. IMAI, H. HOJO, Y. HASHIMOTO and S. NOZOE, Int. J. Immunopharm. 14 1181-1186 (1992).
10. 10. S.Y. LI, L.H LING, B.S. THE, W.K. SEOW and Y.H. THONG, Int. J. Immunopharm. 11 395-401 (1989).
11. 11. W.K. SEOW, A. FERRANTE, A. SUMMORS and Y.H. THONG, Life Sci. 50 PL53-58 (1992).
12. 12. K. YASUKAWA, M. AKASU, M. TAKEUCHI and M. TAKIDO, Oncology-Switzerland, 50 137-140 (1993).
13. 13. Y. KONDO, F. TAKANO and H. HOJO, Biochem. Pharmacol. 46 1861-1863 (1993).
14. 14. I. HASEGAWA, Y. MIZOGUCHI, H. TSUTSUI, Y. ICHIKAWA, N. KAWADA, S. MORISAWA and S. YAMAMOTO, J. Med. Pharm. Soc. 7 24-27 (1990).
15. 15. S. SEN, and M. D'INCALCI, FEBS Lett. 307 122-127 (1992).
16. 16. B.K. BHALLA, C. TANG, A.M., IBRADO, S. GRANT, E. TOURKINE, C. HOLLADAY, M. HUGHES, M.E. MAHONEY, and Y. HUANG, Blood. 80 2883-2890 (1992).
17. 17. Q. SONG, G.D. BAXTER, E.M. KOVACS, D. FINDIK and M.F. LAVIN, J. Cell. Physiol. 153 550-556 (1992)
18. 18. B.S. TEH, P. CHEN, M.F. LAVIN, W.K. SEOW and Y.H. THONG, Int. J. Immunopharm. 13 1117-1126 (1991).
19. 19. Y.M. LEUNG, M. BERDIK, C.Y. KWAN and T.T. LOH, Clin. Exp. Pharmacol. Physiol. 23 653-659 (1996).
20. 20. Y.M. LEUNG, C.Y. KWAN and T.T. LOH, Br. J. Pharmacol. 113 767-774 (1994).